Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Join | Sign in
Home>Products>Product News
  Service News
Aptiv Solutions ADDPLAN® DF is the First Validated Software to Use MCP-Mod Methodology
Thursday, October 31, 2013
MCP-Mod methodology was recently qualified by EMA for reducing bias and error in dose finding clinical trials.

Cobra Biologics Expands Antibody GMP Production Capacity
Tuesday, October 29, 2013
Company installs new 1000L HyClone SUB at the company’s centre of excellence.

Reducing Volume Losses During Fill and Finish
Thursday, October 24, 2013
Company will be presenting a poster at The Universe of Pre-Filled Syringes and Injection Devices PDA conference in Basel.

Cirrus - Kemwell Receives FDA Grant
Thursday, October 10, 2013
Grant to evaluate formulation effects on MDI performance.

Aesica Extends Aseptic Facilities at Nottingham Site
Tuesday, October 08, 2013
Batches can be delivered worldwide for clinical trials and within the EU for small-scale commercial production.

4SC Presents Summary of Biomarker and Patient Subgroup Analysis of Prognostic Factors
Tuesday, October 01, 2013
Further information about proposed role of biomarker ZFP64 in HCC tumour progression presented.

Almac Offering TruSight Tumor Profiling Next-Generation Sequencing Service
Monday, September 30, 2013
TruSight Tumor™ panel is specifically designed for use with FFPE samples.

Almac Launches SupplyTraQ™ Technology Solution
Tuesday, September 24, 2013
Online tool enables more cost-efficient and accurate reconciliation and reporting.

Aptiv Solutions Launches ADDPLAN® DF
Monday, September 23, 2013
An innovative software for optimizing dose selection in phase 2 trials.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 301
Scientific News
NIH Launches Largest Clinical Trial Focused on HIV-related Cardiovascular Disease
Clinical trial to test whether statin administration can reduce the risk for major adverse cardiovascular events.
No Evidence to Change Current Transfusion Practices for Adults
Study found no difference in the primary clinical measure between complex cardiac surgery patients.
Personalized Melanoma Vaccines Marshal Powerful Immune Response
Vaccines target unique mutations in each patient’s tumor.
Repurposed Experimental Cancer Drug Restores Brain Function in Mouse Models
NIH-supported research enables clinical trial to explore treatment for most common form of dementia.
Experimental Ebola Vaccine Safe, Prompts Immune Response
Results from US government-sponsored phase 1 trial of VSV vaccine reported.
Ebola Test Vaccines Appear Safe in Phase 2 Liberian Clinical Trial
Liberia-U.S. partnership planning Phase 3 trial and study of Ebola survivors.
NIH Works to Improve Kidney Health for All
Statement of NIDDK Director Griffin P. Rodgers, M.D., for World Kidney Day 2015.
MorphoSys and Emergent BioSolutions Initiate Phase 1 Clinical Study
Phase 1 study to evaluate the novel oncology immunotherapeutic MOR209/ES414 for prostate cancer.
NIH-supported Clinical Trials to Evaluate Long-acting, Injectable Antiretroviral Drugs
Both trials are expected to be completed in 2017.
Single-Cell, 42-plexed Protein Analysis Achieved with a New Microchip Technology
A novel microdevice capable of detecting 42 unique immune effector proteins has been developed.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters